The ASBMB’s Public Affairs Department encourages all readers of the Policy Blotter to alert the office about interesting and relevant articles. Please send tips to email@example.com.
Today, the ASBMB announced an official partnership with the Walk for Science
Check out a recap of this year’s Hill Day!
Federal investments in the National Institutes of Health since its inception 80 years ago have produced research that has led to significant breakthroughs in the understanding of diseases, ultimately paving the way for the development of vital therapies and treatments available today. This research also has led to advancements and innovations in the technology used to detect and diagnose illnesses, allowing medical professionals to effectively treat their patients. Without these federal investments, many of the advances we have seen over the past eight decades would not exist. The U.S. has been a leader in the bioscience community, with researchers from around the world migrating to America to take advantage of its research infrastructure and opportunities for funding. However, in recent years, the scientific community has witnessed a sharp decline in NIH funding when taking inflation into account. With President Donald Trump’s recent proposal impose massive budget cuts on the NIH, America is in jeopardy of losing its place as the world leader in biomedical innovation and research.
As the national debt quickly approaches $20 trillion, one could argue that the federal government should be looking for ways to curb extraneous spending. However, in his recently released budget proposal, President Trump recommended significant increases to defense spending and devastating cuts to nondefense federal agencies, including close to a 20 percent cut to the NIH. While many in Congress have been outspoken against Trump’s proposal, it is important to look at the detrimental consequences such cuts would have on the future of biomedical research in the United States.